Announcement

Collapse
No announcement yet.

Remdesivir has little effect on Covid-19 mortality, WHO study says

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Remdesivir has little effect on Covid-19 mortality, WHO study says

    Results of highly anticipated Solidarity trial strike a blow to hopes for coronavirus treatments

    Donato Paolo Mancini and Clive Cookson in London
    OCTOBER 15, 2020

    The Covid-19 treatment remdesivir has no substantial effect on a patient’s chances of survival, a clinical trial by the World Health Organization has found, delivering a significant blow to hopes of identifying existing medicines to treat the disease.

    Results from the WHO’s highly anticipated Solidarity trial, which studied the effects of remdesivir and three other potential drug regimens in 11,266 hospitalised patients, found that none of the treatments “substantially affected mortality” or reduced the need to ventilate patients, according to a copy of the study seen by the Financial Times.

    ... The WHO declined to comment, saying the results of the study were not yet public.

    The WHO’s findings mean that the only drug proven to increase Covid-19 survival rates is dexamethasone, a cheap steroid that can be taken orally and is widely available around the world.

    https://www.ft.com/content/ee9b611f-...1-b0b804d17a94

Working...
X